FRANCHI MATTEO

Ruolo:

Ricercatore a tempo determinato

Settore scientifico disciplinare:

STATISTICA MEDICA (MED/01)

Afferenza:

E-mail:

Telefono:

0264485859

Stanza:

U07, Piano: P02, Stanza: 2059
Via Bicocca degli Arcimboldi, 8 - 20126 MILANO

Bonifazi, M., Sverzellati, N., Negri, E., Pomponio, G., Seletti, V., Bonini, M., et al. (2020). Increased prevalence of small airways dysfunction in patients with systemic sclerosis as determined by impulse oscillometry. RHEUMATOLOGY, 59(3), 641-649. Dettaglio
Rea, F., Ieva, F., Pastorino, U., Apolone, G., Barni, S., Merlino, L., et al. (2020). Number of lung resections performed and long-term mortality rates of patients after lung cancer surgery: evidence from an Italian investigation. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. Dettaglio
Franchi, M., Garau, D., Kirchmayer, U., Di Martino, M., Romero, M., Carlo, I., et al. (2020). Effectiveness and costs associated to adding cetuximab or bevacizumab to chemotherapy as initial treatment in metastatic colorectal cancer: Results from the observational fabio project. CANCERS, 12(4), 839. Dettaglio
Trifirò, G., Gini, R., Barone-Adesi, F., Beghi, E., Cantarutti, A., Capuano, A., et al. (2019). The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?. DRUG SAFETY, 42(3), 347-363. Dettaglio
Franchi, M., Barni, S., Tagliabue, G., Ricci, P., Mazzucco, W., Tumino, R., et al. (2019). Effectiveness of First-Line Bevacizumab in Metastatic Colorectal Cancer: The Observational Cohort Study GRETA. THE ONCOLOGIST, 24(3), 358-365. Dettaglio

Futuri studenti